EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

NAKHJAVANI M.; BAIANI MA.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ) Year:2005 | Volume:63 | Issue:3 Page(s): 172-179

Download Full-Text

Persian Verion

View:

1,451

Download:

Cites:

Information Journal Paper

Title

EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS

Author(s)

NAKHJAVANI M. | BAIANI MA. | Issue Writer Certificate

Keywords

METFORMINQ4

INSULIN THERAPYQ4

DIABETESQ4

Abstract

Background: Patients with type 2 DIABETES are often obese and require large dose of insulin to achieve glycemic control. INSULIN THERAPY often cause weight gain and results in increasing insulin requirements. This study was conducted to evaluate the efficacy of METFORMIN in combination with insulin in patients with type 2 DIABETES poorly controlled with INSULIN THERAPY alone.Materials and Methods: In a randomized clinical trial in outpatient DIABETES clinic at university medical center, 39 patients with poorly controlled type 2 DIABETES who were receiving INSULIN THERAPY were randomly assigned to receive METFORMIN in combination with inslin or insulin alone for six months.Results: Hemoglobin A1C levels decreased by 1.56 percentage (95% cl, 0.77 to 2.34 percentage point) in METFORMIN group, a significantly greater change (P=0.008) than the increase of 0.03 percentage points in the insulin alone group. Average final hemoglobin A1C levels were 7.96% in the METFORMIN group and 10.32% in the insulin alone group (difference 17%). For patients who did not received metformin, the insulin dose increased 9.37 units (95% cl 6 to 12 units) or 37% more than did the dose for patients who received metformin. (P<0.0005): for these patients, the insulin dose decreased 6.6 units (95% cl-1.24 to –11.96) Patients in insulin alone group gained an average of 3.08 kg of body weight (95% cl 1.56 to 4.58 kg) patient in the METFORMIN group gained an average of 1.8 kg (95% cl 0.21 to 3.36 kg) Difference (1.9%) was not meaningful. Change of total cholesterol, low density lipoprotein cholestrol and triglyceride levels was not significant.Conclusion: The addition of METFORMIN to INSULIN THERAPY resulted in hemoglobin A1C concentrations that were 17.8% lower than those achieved by INSULIN THERAPY alone. This improvement occurred with use of 37% less insulin. METFORMIN is an effective adjunct to INSULIN THERAPY in patients with type 2 DIABETES.

Cites

No record.

References

No record.

Cite

APA: Copy

NAKHJAVANI, M., & BAIANI, MA.. (2005). EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), 63(3), 172-179. SID. https://sid.ir/paper/39189/en

Vancouver: Copy

NAKHJAVANI M., BAIANI MA.. EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS. TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ)[Internet]. 2005;63(3):172-179. Available from: https://sid.ir/paper/39189/en

IEEE: Copy

M. NAKHJAVANI, and MA. BAIANI, “EFFECTS OF METFORMIN IN INSULIN – TREATED TYPE 2 DIABETES MELLITUS PATIENTS,” TEHRAN UNIVERSITY MEDICAL JOURNAL (TUMJ), vol. 63, no. 3, pp. 172–179, 2005, [Online]. Available: https://sid.ir/paper/39189/en

Related Journal Papers